S100A8/A9 hi neutrophils induce mitochondrial dysfunction and PANoptosis in endothelial cells via mitochondrial complex I deficiency during sepsis.
Yanghanzhao WangYuxin ShiYuwen ShaoXihua LuHao ZhangChang-Hong MiaoPublished in: Cell death & disease (2024)
S100a8/a9, largely released by polymorphonuclear neutrophils (PMNs), belongs to the S100 family of calcium-binding proteins and plays a role in a variety of inflammatory diseases. Although S100a8/a9 has been reported to trigger endothelial cell apoptosis, the mechanisms of S100a8/a9-induced endothelial dysfunction during sepsis require in-depth research. We demonstrate that high expression levels of S100a8/a9 suppress Ndufa3 expression in mitochondrial complex I via downregulation of Nrf1 expression. Mitochondrial complex I deficiency contributes to NAD + -dependent Sirt1 suppression, which induces mitochondrial disorders, including excessive fission and blocked mitophagy, and mtDNA released from damaged mitochondria ultimately activates ZBP1-mediated PANoptosis in endothelial cells. Moreover, based on comprehensive scRNA-seq and bulk RNA-seq analyses, S100A8/A9 hi neutrophils are closely associated with the circulating endothelial cell count (a useful marker of endothelial damage), and S100A8 is an independent risk factor for poor prognosis in sepsis patients.
Keyphrases
- poor prognosis
- endothelial cells
- oxidative stress
- high glucose
- rna seq
- long non coding rna
- diabetic rats
- single cell
- intensive care unit
- acute kidney injury
- septic shock
- end stage renal disease
- cell proliferation
- vascular endothelial growth factor
- ischemia reperfusion injury
- chronic kidney disease
- newly diagnosed
- signaling pathway
- binding protein
- prognostic factors
- weight gain
- optical coherence tomography
- gene expression
- reactive oxygen species
- patient reported outcomes